European Medicines Agency - Regulatory - Regulation of medicines

D - Description



  Description

Name

TREAT-NMD - Neuromuscular Network

Year of foundation 2007
Preterm and/or term newborn Yes
Infants from 1 month to less than 24 months of age Yes
Children from 2 years to less than 12 years of age Yes
Adolescents from 12 years to less than 18 years Yes
Paediatric age ranges of study participants covered by the network 0-18 years
Multispeciality? Specify Neuromuscular diseases
Speciality/disease specific? Specify
Conditions covered? Specify
Procedure/Intervention specific? Specify
Number of collaborating countries 51
List of collaborating countries http://www.treat-nmd.eu/about/membership/organizations/
Number of collaborating centres 138
List of collaborating centres Link to TREAT-NMD Alliance Member Organisations: http://www.treat-nmd.eu/about/membership/organizations/
Type of activity/studies
Clinical Studies No
Experimental research No
Other activity Examples of other activity include Biobanks, Cell and Animal models, Care and trial site registry (CTSR), Genetic testing, Global patient registries, Magnetic resonance imaging (MRI), Next generation sequencing (NGS), Outcome measures, Regulatory links and International standards for diagnosis and care.